ATAD1 and malaria: To measure prior malaria exposure, we measured the initial antibody responses at baseline to MSP-1 (an immunogenic blood-stage antigen) and NF54 schizont extracts in 47 participants (9 individuals were inadvertently excluded from this analysis because of insufficient reagent availability).